reglab/statecodes huggingface dataset:
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › STANDARDS › Section 27.19 - Prospective drug review and patient counseling

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
PDR Required.
A
					 pharmacist shall perform a PDR before filling, delivering or sending a new
					 prescription or drug order, except when a physician dispenses a drug to a
					 patient being treated in the emergency room. The PDR requires that the
					 pharmacist review a profile of the patient maintained in the pharmacy in
					 accordance with subsection (f) prior to dispensing the medication to the
					 patient or caregiver.
(b)
Purpose
. The purpose of the PDR is to help assure that a drug
					 dispensed under a prescription is not likely to have an adverse medical result.
					 The PDR accomplishes this by attempting to identify potential drug therapy
					 problems that might result from therapeutic duplication, drug-drug
					 interactions, incorrect dosage, incorrect duration of drug treatment,
					 drug-allergy interactions, and clinical abuse or misuse.
(c)
Scope
.
(1) The PDR is required for prescriptions and
					 drug orders.
(2) The following are
					 examples of situations in which a PDR is required:
(i) A patient visits a physician in the
					 physician's office and receives a prescription. The patient has the
					 prescription filled in a retail pharmacy.
(ii) A pharmacist fills a prescription for a
					 patient who lives in a personal care home.
(iii) A pharmacist in a hospital pharmacy
					 fills an outpatient prescription for a hospital employee.
(iv) A patient is treated on a nonemergency
					 basis in an outpatient clinic of a hospital and is given a prescription. The
					 patient has the prescription filled either in the hospital pharmacy or in a
					 retail pharmacy.
(v) A pharmacist
					 fills a prescription for a patient in a nursing home.
(vi) A pharmacist in a hospital dispenses a
					 drug which will be administered to a patient in the hospital.
(3) The following are examples of
					 situations in which a PDR is not required:
(i)
					 A physician dispenses a drug to a patient being treated in the emergency
					 room.
(ii) A pharmacist dispenses a
					 radiopharmaceutical to a physician who will administer it to a
					 patient.
(iii) A medical
					 practitioner dispenses a drug.
(iv)
					 A pharmacist dispenses a drug to a medical practitioner which the practitioner
					 will administer to a patient.
(v) A
					 pharmacist delivers naloxone to an identified employee of a Pennsylvania
					 correctional facility, prison, jail or residential drug treatment facility
					 under a prescription and for an identified individual who is pending release or
					 discharge from the correctional facility, prison, jail or residential drug
					 treatment facility.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › STANDARDS › Section 27.20 - Facsimile machines

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Schedule II controlled substances.
(1) A pharmacist may fill a prescription for
					 a Schedule II controlled substance which was received on a facsimile machine if
					 the original prescription signed by the medical practitioner is presented to
					 the pharmacist for review prior to the actual dispensing of the controlled
					 substance. The original prescription shall be maintained as the original
					 pharmacy record.
(2) There are
					 three exceptions to the requirement that the pharmacist review the original of
					 the prescription received on a facsimile machine before dispensing a Schedule
					 II controlled substance. A pharmacist may fill and dispense a prescription for
					 a Schedule II controlled substance which was received on a facsimile machine
					 and may use the facsimile as the original pharmacy record of the following:
(i) A prescription for a Schedule II
					 controlled narcotic substance to be compounded for the direct administration to
					 a patient by parenteral, intravenous, intramuscular, subcutaneous or
					 intraspinal infusion in the patient's home.
(ii) A prescription for a Schedule II
					 controlled substance for a resident of a long-term care facility.
(iii) A prescription for a Schedule II
					 controlled narcotic substance for a patient enrolled in a hospice care
					 program.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PHARMACISTS › Section 27.21 - Application for examination and licensure

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A candidate for licensure to practice
					 pharmacy by examination applying to take the North American Pharmacist
					 Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence
					 Examination (MPJE) shall obtain an application for licensure from the Board,
					 complete the application and file the application with the Board.
(b) The applicant shall include in the
					 application proof of graduation with a B.S. or advanced degree in pharmacy
					 granted by an ACPE accredited school or college; affidavits of all internship
					 experience gained prior to submitting the application; and the application
					 fee.
(c) The applicant shall also
					 complete and submit the examination fees and examination registration forms to
					 the test administrator.
(d)
					 Affidavits of internship experience shall be filed before authorization to take
					 the exam is given.
The provisions of this §
													27.21 amended under section
						  812.1 of The Administrative Code
						  of 1929 (71 P. S. §
														279.3a); and
						  sections 3, 4(j), 6(k) and 8.2 of the Pharmacy Act (63 P. S. §§
														390-3,
						  390-4(j), 390-6(k) and
						  8.2).
This section cited in 49 Pa. Code §
													27.52 (relating to graduates of
						  foreign schools and noncitizens).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PHARMACISTS › Section 27.22 - Application after expulsion from examination

Current through Register Vol. 54, No. 28, July 13, 2024
An applicant for an examination and registration as a
						licensed pharmacist who has been expelled from an examination room for
						cribbing, cheating or other dishonest conduct may not be permitted to file a
						new application for examination within 1 year thereafter, and shall petition
						the Board specially for permission to take a subsequent
						examination.
This section cited in 49 Pa. Code §
													27.52 (relating to graduates of
						  foreign schools and noncitizens).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PHARMACISTS › Section 27.23 - Time and place for holding examination

Current through Register Vol. 54, No. 28, July 13, 2024
Examinations shall be held at times and places and
						determined by the Board in conjunction with the test
						administrator.
This section cited in 49 Pa. Code §
													27.52 (relating to graduates of
						  foreign schools and noncitizens).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PHARMACISTS › Section 27.24 - Examinations and passing scores

Current through Register Vol. 54, No. 28, July 13, 2024
On and after March 1, 1997, but before November 1, 1998,
						candidates for licensure by examination are required to pass both the North
						American Pharmacist Licensure Examination (NAPLEX) and the Federal Drug Law
						Examination (FDLE), developed and administered by the National Association of
						Boards of Pharmacy (NABP).
(b) On and
					 after November 1, 1998, candidates for licensure by examination are required to
					 pass both the NAPLEX and the Multistate Pharmacy Jurisprudence Examination
					 (MPJE), developed and administered by the NABP.
(c) The minimum passing score on each
					 examination will be as determined by the NABP.
The provisions of this §
													27.24 amended under section
						  812.1 of The Administrative Code
						  of 1929 (71 P. S. §
														279.3a); and
						  sections 3, 6(k) and 8.2 of the Pharmacy Act (63 P. S. §§
														390-3,
						  390-6(k) and
						  390-8.2).
This section cited in 49 Pa. Code §
													27.52 (relating to graduates of
						  foreign schools and noncitizens).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PHARMACISTS › Section 27.25 - Licensure by reciprocity

Current through Register Vol. 54, No. 28, July 13, 2024
(a) An
					 applicant for licensure by reciprocity shall comply with section 3(g) of the
					 act (63 P. S. §
												390-3(g)).
(b) Except as provided in subsection (c), an
					 applicant for licensure by reciprocity who received a license to practice
					 pharmacy in any other state, territory or possession of the United States,
					 after January 26, 1983, shall be required to demonstrate that the applicant
					 passed the FDLE.
(c) If an
					 applicant licensed after January 26, 1983, cannot demonstrate that the
					 applicant passed the FDLE, the applicant shall be required to demonstrate that
					 the applicant passed the Pennsylvania MPJE.
This section cited in 49 Pa. Code §
													27.52 (relating to graduates of
						  foreign schools and noncitizens).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PHARMACISTS › Section 27.26 - Pharmacy internship

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
					 Pharmacy internship means the supervised practical experience required for
					 licensure as a registered pharmacist. The purpose of the pharmacy internship
					 program is to provide a registered intern with the knowledge and practical
					 experience necessary for functioning competently and effectively upon
					 licensure.
(b) Registration as a
					 pharmacy intern will be available to an individual of good moral character who
					 has completed at least 2 years of college and is enrolled or accepted as a
					 student of pharmacy in an ACPE-accredited pharmacy degree program. A person
					 desiring to register as a pharmacy intern shall do the following:
(1) Apply to the Board for registration
					 including the fee specified in §
												27.91 (relating to schedule of
					 fees) for registering as a pharmacy intern.
(2) Forward to the Board acceptable
					 documentation verifying that the applicant has successfully completed at least
					 2 years of college and is enrolled or accepted as a student of pharmacy in an
					 ACPE-accredited pharmacy degree program. Acceptable documentation includes a
					 document bearing the school's seal received by the Board directly from the dean
					 or registrar of the ACPE-accredited pharmacy degree program which includes the
					 pharmacy student's name, address, Social Security number, and a statement
					 indicating that the student has successfully completed at least 2 years of
					 college and is enrolled or accepted as a student of pharmacy in, or has
					 graduated from, the ACPE-accredited pharmacy degree program.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › RENEWAL OF PHARMACIST LICENSE AND PHARMACY PERMIT › Section 27.31 - Biennial renewal

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A
					 holder of a pharmacy permit shall renew the permit every 2 years, in odd-number
					 years. Renewal requires completion of a form mailed to the holder by the Board
					 in advance of the renewal period, and payment of the specified fee.
(b) A licensed pharmacist shall renew the
					 license every 2 years, in even-numbered years. Renewal requires completion of a
					 form mailed to the pharmacist by the Board in advance of the renewal period or
					 completion of an online electronic form, and payment of the specified fee. A
					 pharmacist shall also submit proof of compliance with the continuing education
					 requirements of §
											27.32 (relating to continuing
					 education).
(c) A pharmacist or
					 holder of a pharmacy permit who fails to timely renew shall cease practice or
					 operation until the license or permit is renewed. The holder may be subject to
					 disciplinary action, and will be assessed an additional fee of $5 for each
					 month or part of month after which renewal occurs beyond the date specified by
					 the Board. Notice of lapsed pharmacy permits shall be forwarded to other
					 Commonwealth agencies, including the Department of Health, the Department of
					 Public Welfare and the Department of Aging.
(d) A pharmacist allowing the license to
					 lapse may so notify the Board on the renewal form. Reasons shall be briefly
					 stated, and the pharmacist's pocket license and display license shall be
					 surrendered to the Board with the renewal form. A pharmacist who has had a
					 lapsed license for 1 year or more, and who then seeks to reactivate the
					 license, will be required to show current proficiency to practice pharmacy. The
					 full-time practice of pharmacy in another state, during the period of lapsed
					 licensure in this Commonwealth, will be evidence of current proficiency. A
					 holder of a lapsed license who engaged in activities outside the profession of
					 pharmacy during the lapsed period shall complete hours of continuing education
					 equivalent to the hours which he would have been required to take had he held
					 an active license.
This section cited in 49 Pa. Code §
													43b.7 (relating to schedule of
						  civil penalties-pharmacists and pharmacies); and 49 Pa. Code §
													43b.7a (relating to schedule of
						  civil penalties-pharmacists and pharmacies-statement of
						  policy).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › INSTITUTIONS › Section 27.41 - Qualified institutions

Current through Register Vol. 54, No. 28, July 13, 2024
Only institutions accredited by the Joint Commission on
						Accreditation of Hospitals or the Commission on Hospital Accreditation of the
						American Osteopathic Association or meeting the requirements of the "Conditions
						of Participation for Extended Care Facilities," Federal Health Insurance for
						the Aged, or licensed by the Department of Welfare or Department of Health,
						will be considered for an application for a permit to operate a pharmacy. An
						institution may not be consid-ered for a pharmacy permit unless the pharmacy in
						that institution is open a minimum of 20 hours per week under the supervision
						of a registered pharmacist manager.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › INSTITUTIONS › Section 27.42 - Institutional regulation

Current through Register Vol. 54, No. 28, July 13, 2024
Pharmaceutical services in institutions shall always be
						conducted in accordance with rules and regulations affecting the services which
						have been or may hereafter be promulgated by the Department of Public Welfare
						or Department of Health, and the rules and regulations are hereby incorporated
						automatically. Violation of the rules and regulations constitute a violation of
						this chapter.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › ELIGIBILITY OF NONCITIZENS › Section 27.51 - Age

Current through Register Vol. 54, No. 28, July 13, 2024
A person who has reached his 21st birthday and is a
						graduate of a college of pharmacy accredited by the American Council of
						Pharmaceutical Education or a college of pharmacy which meets educational
						qualifications and requirements of and is approved by the Board, and otherwise
						meets legal requirements shall be eligible for licensure to practice pharmacy
						in this Commonwealth.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › ELIGIBILITY OF NONCITIZENS › Section 27.52 - Graduates of foreign schools and noncitizens

Current through Register Vol. 54, No. 28, July 13, 2024
(a) Graduates of foreign schools and
					 noncitizens are eligible to become licensed to practice in this Commonwealth if
					 they meet the requirements and qualifications of the act and this
					 chapter.
(b) Graduates of foreign
					 schools and noncitizens are advised that licenses obtained in this Commonwealth
					 may not be accepted by other states under present reciprocal arrangements. The
					 Board recommends that graduates of foreign schools and noncitizens who
					 anticipate practicing in another state in the future should make immediate
					 application to that state.
(c) If a
					 graduate of a foreign college has had experience in the practice of pharmacy
					 and demonstrates knowledge of American pharmacy practices and is proficient
					 generally in his ability to communicate in the English language, the Board may
					 approve a special internship program of less than 1,500 hours, but in no case
					 less than 500 hours. The Board may waive the theoretical examination for a
					 graduate, but he will be required to take the practical examination.
(d) Graduates of foreign colleges are subject
					 to the provisions set forth in §§
											27.21-27.26 (relating to
					 pharmacists).
(e) The Board
					 recognizes those schools or colleges of pharmacy that are accredited by the
					 American Council of Pharmaceutical Education. This body is a national
					 accrediting agency which establishes the standards for colleges of pharmacy and
					 sees that these standards are maintained in the colleges of pharmacy that have
					 been accredited and approved. Since foreign colleges are not accredited by the
					 American Council of Pharmaceutical Education, the Board, with the cooperation
					 and advice of the United States Department of Education and the Pennsylvania
					 Department of Education, may approve foreign colleges of pharmacy and
					 nonaccredited American schools on a case by case basis if they meet the
					 standards and qualifications of the Board. The Board may also, without
					 approving a school, approve individual applications of qualified graduates of
					 schools on a case by case basis.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › BRIBERY › Section 27.61 - In general

Current through Register Vol. 54, No. 28, July 13, 2024
It shall constitute unprofessional conduct and a
						violation of this chapter for a licensee of the Board to do the
						following:
(1) Directly or indirectly
					 to offer or give money or an item of value to an employe of the Commissioner of
					 Professional and Occupational Affairs or any Board or Commission assigned to
					 the administrative jurisdiction of the Commissioner of Professional and
					 Occupational Affairs, except for the payment required by the act and the rules
					 and regulations of the State Board of Professional and Occupational Affairs, in
					 accordance therewith.
(2) To fail
					 to notify in writing the Commissioner at 279 Boas Street, Harrisburg,
					 Pennsylvania 17120 of a demand, solicitation or attempted extortion of money or
					 an item of value by, or on behalf of, an employe of the Commissioner or a board
					 or commission assigned to the administrative jurisdiction of the Commissioner
					 within 5 days thereafter and to furnish the additional information in
					 connection as might reasonably be requested.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › MISCELLANEOUS › Section 27.71 - Revocation and suspension

Current through Register Vol. 54, No. 28, July 13, 2024
Failure to comply with this chapter shall be grounds for
						revocation or suspension of licensure under section 5(a)(6) of the act
						(63
						P. S. §
												390-5(a)(6)).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › APPLICABILITY OF GENERAL RULES › Section 27.81 - Applicability of general rules

Current through Register Vol. 54, No. 28, July 13, 2024
Under 1 Pa. Code §
											31.1 (relating to scope of part),
						1 Pa. Code Part II (relating to general rules of administrative practice and
						procedure), are applicable to the activities of and proceedings before the
						Board.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › FEES › Section 27.91 - Schedule of fees

Current through Register Vol. 54, No. 28, July 13, 2024
An applicant for a license, certificate, permit or
						service shall pay the following fees at the time of application:
Application for pharmacy intern certificate ...
						$35
Application for pharmacist license ... $45
Certification of examination scores or internship hours
						... $25
Verification of licensure ... $15
Assistant pharmacist biennial renewal ... $120
Registered pharmacist biennial renewal ... $190
Registered pharmacist late renewal penalty ... $25
New pharmacy permit application ... $125
Reinspection of new pharmacy after failure at first
						inspection ... $115
Pharmacy permit change without inspection ... $45
Pharmacy permit change when inspection required ...
						$125
Change in pharmacy ownership or Board of Directors ...
						$30
Verification of permit ... $15
Biennial renewal of pharmacy permit ... $125
Pharmacy permit late renewal penalty ... $25
Application for approval to administer injectables ...
						$30
Biennial renewal of approval to administer injectables
						... $30
The provisions of this §
													27.91 issued under sections 3,
						  4(j), 6(k)(1), 8.2 and 9.2(a) of the Pharmacy Act (63 P. S. §§
														390-3,
						  390-4(j), 390-6(k)(l),
						  390-8.2 and 390-9.2(a)); amended under section
						  812.1 of The Administrative Code
						  of 1929 (71 P. S. §
														279.3a).
This section cited in 49 Pa. Code §
													27.26 (relating to pharmacy
						  internship); and 49 Pa. Code §
													27.402 (relating to application,
						  renewal and reactivation
						  procedures).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › STATEMENTS OF POLICY › Section 27.101 - Radiopharmaceutical prescriptions-statement of policy

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Definition
. The term
					 "radiopharmaceutical" means a pharmaceutical, biological or drug which contains
					 a radioactive entity.
(b)
Unavailable name
. When a pharmacist receives a prescription
					 for a radiopharmaceutical for a patient whose name is unavailable at the time
					 the prescription is received and the pharmacist dispenses the
					 radiopharmaceutical, the pharmacist and pharmacy will be considered to have
					 complied with the provisions of §
											27.18(b) and (d)
					 (relating to standards of practice) which require the name of the patient if
					 the pharmacist obtains the name of the patient within 72 hours after dispensing
					 the radiopharmaceutical or, if the radiopharmaceutical is not administered to a
					 patient, marks the prescription "not used."
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › STATEMENTS OF POLICY › Section 27.102 - Return to stock of undelivered medication-statement of policy

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Background and purpose.
Section 5(a)(9)(xi) of the act (63 P. S. §
												390-5(a)(9)(xi)) prohibits
					 the return to stock of medication once it has left the premises of the
					 pharmacy. However, many prescriptions do not get delivered to patients and,
					 therefore never leave the control of the pharmacy. These prescriptions may be
					 returned to the active stock of the pharmacy. This section sets forth the
					 guidelines that should be considered when returning undelivered medication to
					 the pharmacy's active stock. This section will insure that the integrity of the
					 drugs is maintained and patient safety is not compromised.
(b)
Guidelines.
The
					 following guidelines should be considered when returning undelivered
					 medications to stock to assure that the quality of medications is maintained:
(1) Prescriptions that have not been picked
					 up by or delivered to patients should be checked periodically.
(2) Prescriptions not delivered to patients
					 should be assessed by a pharmacist to determine whether they might safely be
					 returned to stock.
(3) Products
					 deemed eligible for redispensing should never be mixed within stock bottles of
					 different lot numbers or with different expiration dates. Manufacturers' stock
					 bottles should never be over-filled. The only safe manner in which drugs can be
					 returned to stock bottles is in those pharmacies in which all medications are
					 tracked by lot numbers and expiration dates.
(4) In those instances in which medication
					 cannot be properly and safely returned to the original stock bottle, the
					 medication may be held in the pharmacy in the container in which it has been
					 repackaged. It is recommended that pharmacies develop an internal manner for so
					 identifying and dating these products.
(5) Medications held for redispensing should
					 be used as soon as possible. Medications held for redispensing, lacking
					 original lot numbers and expiration dates, should only be dispensed to patients
					 up to 6 months from the date the drugs were first prepared for
					 dispensing.
(6) If the manufacturer
					 or the United States Food and Drug Administration orders a recall for a drug
					 product, pharmacists should assume products held in containers without lot
					 numbers are included in the recall and proceed accordingly.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › TECHNOLOGY AND AUTOMATION › Section 27.201 - Electronically transmitted prescriptions

Current through Register Vol. 54, No. 28, July 13, 2024
(a) For the purposes of this section, an
					 electronically transmitted prescription means the communication of an original
					 prescription or refill authorization by electronic means, to include
					 computer-to-computer, computer-to-facsimile machine or e-mail transmission
					 which contains the same information it contained when the authorized prescriber
					 transmitted it. The term does not include a prescription or refill
					 authorization transmitted by telephone or facsimile machine.
(b) A pharmacist may accept an electronically
					 transmitted prescription from an authorized licensed prescriber or an
					 authorized designated agent which has been sent directly to a pharmacy of the
					 patient's choice if all the following requirements are met:
(1) The prescription must contain the
					 signature or the electronic equivalent of a signature of the prescriber made in
					 accordance with the requirements of the Electronic Transactions Act
					 (73
					 P. S. §§
													2260.101-2260.5101).
(2) The prescription must include the
					 following information:
(i) The information
					 that is required to be contained on a prescription under State and Federal
					 law.
(ii) The prescriber's
					 telephone number.
(iii) The date of
					 the transmission.
(iv) The name of
					 the pharmacy intended to receive the transmission.
(3) The prescription must be electronically
					 encrypted or transmitted by other technological means designed to protect and
					 prevent access, alteration, manipulation or use by any unauthorized
					 person.
(4) A hard copy or a
					 readily retrievable image of the prescription information that is transmitted
					 shall be stored for at least 2 years from the date of the most recent
					 filling.
(5) The electronic
					 transmission of a prescription for a Schedule II, III, IV or V controlled
					 substance is considered a written prescription order on a prescription blank
					 and may be accepted by a pharmacist provided that the transmission complies
					 with this chapter and other requirements under Federal or other State laws or
					 regulations, including The Controlled Substance, Drug, Device and Cosmetic Act
					 (35
					 P. S. §§
													780-101-780-144),
					 Department of Health regulations in 28 Pa. Code §§
												25.1-25.131 and Federal rules
					 established by the United States Drug Enforcement Administration in 21 CFR Part
					 1311 (relating to requirements for electronic orders and
					 prescriptions).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › TECHNOLOGY AND AUTOMATION › Section 27.202 - Computerized recordkeeping systems

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A computerized system used by a pharmacy
					 for recording and maintaining information concerning prescriptions under State
					 and Federal laws must be designed so that it is capable of providing immediate
					 retrieval, by means of monitor, hard-copy printout or other transfer medium, of
					 patient information for all prescriptions filled within the previous 12 months
					 and retrieval within 3 working days of all prescriptions dispensed within the
					 previous 24 months from the last activity date. This information must include
					 the following data:
(1) The information
					 required to be on prescriptions under §
												27.18(b)(1)
					 (relating to standards of practice).
(2) Identification of the pharmacist
					 responsible for prescription information entered into the computer
					 system.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › TECHNOLOGY AND AUTOMATION › Section 27.203 - Centralized prescription processing

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Centralized prescription
					 processing
. A central fill pharmacy or central processing center may
					 fulfill a request for the processing, filling or refilling of a prescription
					 from either the originating pharmacy or from the patient or the prescriber and
					 may deliver the processed, filled or refilled prescription to a delivering
					 pharmacy if the following requirements are met:
(1) The central fill pharmacy or the central
					 processing center that is to process, fill or refill the prescription has a
					 contract with or has the same owner as the originating pharmacy and the
					 delivering pharmacy. Contractual provisions must include confidentiality of
					 patient information.
(2) The
					 prescription container:
(i) Is clearly labeled
					 with the information required by Federal and State laws and
					 regulations.
(ii) Clearly shows the
					 name, address, telephone number and DEA number of the delivering
					 pharmacy.
(3) Pharmacies
					 that either utilize or act as central fill pharmacies or central processing
					 centers shall create operating policies and procedures. The policies and
					 procedures must include an audit trail that records and documents the central
					 prescription process and the individuals accountable at each step in the
					 process for complying with Federal and State laws and regulations including
					 recordkeeping.
(4) Pharmacies that
					 engage in centralized prescription processing share a common electronic
					 file.
(5) Each pharmacy engaging in
					 centralized prescription processing shall be jointly responsible for properly
					 filling the prescription.
(6) The
					 delivering pharmacy is responsible for making the offer to counsel to the
					 patient under §
												27.19(e)
					 (relating to prospective drug review and patient
					 counseling).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › TECHNOLOGY AND AUTOMATION › Section 27.204 - Automated medication systems

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
					 This section establishes standards applicable to licensed pharmacies that
					 utilize automated medication systems which may be used to store, package,
					 dispense or distribute prescriptions.
(b) A pharmacy may use an automated
					 medication system to fill prescriptions or medication orders provided that:
(1) The pharmacist manager, or the pharmacist
					 under contract with a long-term care facility responsible for the dispensing of
					 medications if an automated medication system is utilized at a location which
					 does not have a pharmacy onsite, is responsible for the supervision of the
					 operation of the system.
(2) The
					 automated medication system has been tested and validated by the pharmacy and
					 found to dispense accurately prior to the implementation of the system. The
					 pharmacy shall make the results of the testing available to the Board upon
					 request.
(3) The pharmacy shall
					 make the automated medication system available to the Board for the purpose of
					 inspection, whereby the Board may validate the accuracy of the
					 system.
(4) The automated
					 medication system must electronically record the activity of each pharmacist,
					 technician or other authorized personnel with the time, date and initials or
					 other identifier so that a clear, readily retrievable audit trail is
					 established. A pharmacist will be held responsible for transactions performed
					 by that pharmacist or under the supervision of that
					 pharmacist.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › MANAGEMENT OF DRUG THERAPY › Section 27.301 - Written protocol for the management of drug therapy in an institutional setting

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
					 management of drug therapy under section 9.1 of the act (63 P. S. §
												390-9.1) shall be performed under a written
					 protocol consistent with the institution's assignment of clinical duties.
					 Ordering of laboratory tests and ordering or performing other diagnostic tests
					 necessary in the management of drug therapy shall be consistent with the
					 testing standards of the institution.
(b) The written protocol for management of
					 drug therapy between physicians and pharmacists must contain:
(1) A statement identifying the physician
					 responsible for authorizing management of drug therapy.
(2) A statement identifying the pharmacist
					 authorized to perform management of drug therapy.
(3) A statement requiring that regimens for
					 the management of drug therapy be initiated by a physician for patients
					 referred to a pharmacist for management of drug therapy.
(4) A statement identifying the types of
					 decisions regarding the management of drug therapy that the pharmacist is
					 authorized to make, including a statement of the ailments or diseases involved
					 within the physician's scope of practice, and types of management of drug
					 therapy authorized.
(5) A statement
					 of the functions and tasks the pharmacist shall follow in the course of
					 exercising management of drug therapy, including the method for documenting
					 decisions made and a plan for communication or feedback to the authorizing
					 physician concerning specific decisions made. Documentation of each
					 intervention shall occur as soon as practicable, but no later than 72 hours
					 after the intervention in the patient's medical record and shall also be
					 recorded in the pharmacist's records.
(6) A statement that requires notification to
					 the authorizing physician of any changes in dose, duration or frequency of
					 medication prescribed as soon as practicable but no longer than 72 hours after
					 the change.
(7) A provision for
					 implementation of the written protocol when a physician or pharmacist who is a
					 party to the protocol is temporarily unavailable to participate in its
					 implementation.
(8) A provision for
					 notification of the role of the pharmacist by a physician to each referred
					 patient the management of whose drug therapy may be affected by the written
					 protocol and providing an opportunity for the patient to refuse management of
					 drug therapy by a pharmacist.
(9)
					 The signatures of the physicians and pharmacists who are entering into the
					 written protocol, and the dates signed.
(10) A statement allowing for the termination
					 of the written protocol at the request of any party to it at any
					 time.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PROFESSIONAL LIABILITY INSURANCE › Section 27.311 - Certification of professional liability insurance-written protocol

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A licensee who
					 engages in management of drug therapy under a written protocol shall maintain
					 professional liability insurance in the minimum amount of $1 million per
					 occurrence or claims made. The Board will accept from a licensee as
					 satisfactory evidence of insurance coverage any of the following:
(1) Personally purchased professional
					 liability insurance.
(2)
					 Professional liability insurance coverage provided by the individual licensee's
					 employer.
(3) Similar insurance
					 coverage acceptable to the Board.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › PROFESSIONAL LIABILITY INSURANCE › Section 27.312 - Certification of professional liability insurance-collaborative agreement

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A licensee who
					 is a party to a collaborative agreement authorizing the management of drug
					 therapy shall obtain and maintain a level of professional liability insurance
					 coverage in the minimum amount of $1 million per occurrence or claims made. The
					 Board will accept from a licensee as satisfactory evidence of insurance
					 coverage any of the following:
(1) Personally
					 purchased liability insurance.
(2)
					 Professional liability insurance coverage provided by the individual licensee's
					 employer.
(3) Similar insurance
					 coverage acceptable to the Board.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › ADMINISTRATION OF INJECTABLE MEDICATIONS, BIOLOGICALS AND IMMUNIZATIONS › Section 27.401 - Qualifications for authority

Current through Register Vol. 54, No. 28, July 13, 2024
A pharmacist or pharmacy intern may apply to the Board
						for authority to administer injectable medications, biologicals and
						immunizations. A candidate for authority to administer injectable medications,
						biologicals and immunizations shall meet the following requirements:
(1) The pharmacist holds an active license to
					 practice pharmacy or the pharmacy intern holds an active intern registration in
					 this Commonwealth.
(2) The
					 pharmacist or pharmacy intern has completed a course of education and training
					 which meets the requirements of §
											27.407 (relating to education
					 requirements).
(3) The pharmacist
					 or pharmacy intern holds a current basic cardio-pulmonary resuscitation (CPR)
					 certificate issued by the American Heart Association, American Red Cross or a
					 similar health authority or professional body approved by the Board.
The provisions of this §
													27.401 amended under sections
						  4(j), 6(k)(1) and (9) and 9.2(a) of the Pharmacy Act (63 P.S.
						  §§
														390-4(j),
						  390-6(k)(1) and (9) and
						  390-9.2(a)).
This section cited in 49 Pa. Code §
													27.12 (relating to practice of
						  pharmacy and delegation of duties); 49 Pa. Code §
													27.32 (relating to continuing
						  education); and 49 Pa. Code §
													27.403 (relating to conditions for
						  administration).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › ADMINISTRATION OF INJECTABLE MEDICATIONS, BIOLOGICALS AND IMMUNIZATIONS › Section 27.402 - Application, renewal and reactivation procedures

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Application.
An
					 applicant for authority to administer injectable medications, biologicals and
					 immunizations shall submit the following to the Board:
(1) An application obtained from the Board
					 along with the fee required by §
												27.91 (relating to schedule of
					 fees).
(2) Certification that the
					 applicant has completed the required education and training in §
												27.407 (relating to education
					 requirements).
(3) Certification
					 that the applicant holds an acceptable, current CPR
					 certificate.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › ADMINISTRATION OF INJECTABLE MEDICATIONS, BIOLOGICALS AND IMMUNIZATIONS › Section 27.403 - Conditions for administration

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A
					 pharmacist or pharmacy intern who is granted authority may administer
					 injectable medications, biologicals and immunizations to persons who are more
					 than 18 years of age. A person is more than 18 years of age on the day
					 following the person's 18th birthday.
(b) A pharmacist or pharmacy intern who is
					 granted authority may administer influenza immunizations by injectable or
					 needle-free delivery methods to persons 9 years of age or older.
(c) A pharmacist may not delegate the
					 administration of injectable medications, biologicals and immunizations to
					 another person.
(d) A pharmacy
					 intern who has been authorized by the Board to administer injectable
					 medications, biologicals and immunizations to persons who are more than 18
					 years of age and influenza immunizations by injectable or needle-free delivery
					 methods to persons 9 years of age or older under §
											27.401 (relating to qualifications
					 for authority) may do so only under the direct, immediate and personal
					 supervision of a pharmacist who holds an active authority to administer
					 injectable medications, biologicals and immunizations.
(e) A pharmacist or pharmacy intern shall
					 administer injectable immunizations in accordance with treatment guidelines
					 established by a physician and the Centers for Disease Control and Prevention,
					 Advisory Committee on Immunization Practices Guidelines or another competent
					 authority approved by the Board.
The provisions of this §
													27.403 amended under sections
						  4(j), 6(k)(1) and (9) and 9.2(a) of the Pharmacy Act (63 P.S.
						  §§
														390-4(j),
						  390-6(k)(1) and (9) and
						  390-9.2(a)).
This section cited in 49 Pa. Code §
													27.12 (relating to practice of
						  pharmacy and delegation of duties).
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › ADMINISTRATION OF INJECTABLE MEDICATIONS, BIOLOGICALS AND IMMUNIZATIONS › Section 27.404 - Authority and requirements

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A
					 pharmacist or pharmacy intern authorized by the Board to administer injectable
					 medications, biologicals and immunizations may only do so under either an order
					 or written protocol.
(b) The order
					 from a licensed prescriber must be written, received electronically or if
					 received orally be reduced to writing, and contain at a minimum the following:
(1) The identity of the licensed prescriber
					 issuing the order.
(2) The identity
					 of the patient to receive the injection.
(3) The identity of the medication,
					 immunization or vaccine, and dose, to be administered.
(4) The date of the original order and the
					 date or schedule, if any, of each subsequent administration.
Pennsylvania Code › Title 49 - PROFESSIONAL AND VOCATIONAL STANDARDS › Part I - DEPARTMENT OF STATE › Subpart A - PROFESSIONAL AND OCCUPATIONAL AFFAIRS › Chapter 27 - STATE BOARD OF PHARMACY › ADMINISTRATION OF INJECTABLE MEDICATIONS, BIOLOGICALS AND IMMUNIZATIONS › Section 27.405 - Recordkeeping

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A pharmacist
					 who administers an injectable medication, biological or immunization or who
					 supervises the administration by a pharmacy intern shall maintain the following
					 records regarding each administration for a minimum of 2 years:
(1) The name, address and date of birth of
					 the patient.
(2) The date of the
					 administration and site of the injection.
(3) The name, dose, manufacturer, lot number
					 and expiration date of the medication, biological or immunization.
(4) The name and address of the patient's
					 primary health care provider, as identified by the patient.
(5) The name or identifiable initials of the
					 administering pharmacist. If the administration was performed by a pharmacy
					 intern, the name or identifiable initials of the pharmacy intern and the
					 supervising pharmacist.
(6)
					 Documentation of informed consent for administration of injectable medications,
					 biologicals and immunizations, and in the case of influenza immunizations
					 administered to patients under 18 years of age, documentation of written
					 parental consent.
(7) The nature of
					 an adverse reaction and who was notified.